Tom Kean Jr. faces scrutiny over stock transactions during medical leave

Representative Tom Kean Jr. is facing renewed scrutiny over his stock transactions, particularly those made while he was on medical leave. Four years prior, Kean successfully used stock trading controversies against his opponent, Rep. Tom Malinowski, who was dubbed 'Trading Tom' by Republicans for failing to report stock trades and facing scrutiny from the House Ethics Committee. Malinowski ultimately lost to Kean by a narrow margin.

Upon becoming a member-elect, Kean had pledged to place his stocks into a Qualified Blind Trust (QBT), a common mechanism for members of Congress to divest themselves from investment decision-making and avoid conflicts of interest. QBTs are exempt from the reporting requirements under the STOCK Act of 2012. However, Kean encountered difficulties when attempting to implement specific restrictions, such as prohibiting short-selling American companies or investing in entities tied to foreign adversaries. The House Ethics Committee rejected these limitations, preventing him from establishing a standard QBT.

As a workaround, Kean announced in 2025 the creation of an alternative, unofficial 'blind structure' managed by independent advisers without his direct involvement. While this structure allowed him to enact his desired restrictions, it necessitated that his advisers file reports on individual stock transactions, which Kean himself would still need to sign. Kean's attorney, Steve Roberts, stated in a June 2025 letter to House Ethics Committee Chair Michael Guest that Kean "does not direct, influence, or participate in any stock and investment trading activity whatsoever."

Kean told POLITICO that he believes his structure is superior to any other member of Congress, suggesting it would foster greater public faith in the institution. However, the reports Kean filed during his medical absence, first reported by NOTUS, have drawn additional scrutiny. Critics have questioned how Kean could sign off on nearly two dozen stock trades if he was unable to attend work due to medical reasons. Former Rep. Leonard Lance, who previously served on the House Ethics Committee, indicated that Kean appears to have "scrupulously" followed the law, which mandates reporting all transactions exceeding $1,000, even those unknown to the member.